# Humacyte Plans November Dialysis Application, Projects Fourth-Quarter Symvess Sales

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54352
Published: 2026-11-11T19:09:30.000Z
Updated: 2026-11-11T19:09:30.000Z
Section: Business

> The filing would be a supplemental biologics license application, or sBLA.

Humacyte projects Symvess sales for the fourth quarter. The company also plans to submit a supplemental biologics license application (sBLA) for dialysis in November.